Methods for determining nucleotide sequence information

• US 20070031861A1
• Filed: 04/28/2006
• Published: 02/08/2007
• Est. Priority Date: 12/29/2003
• Status: Abandoned Application

• Current Assignee: Intel Corporation
• Original Assignee: Intel Corporation
• Inventors: Su, Xing
• Application Number:
  US11/414,611
• Publication Number:
  US 20070031861A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6818 involving interaction of two or more labels, e.g. resonant energy transfer
• CPC Class Codes: C12Q 1/6874 involving nucleic acid arrays, e.g. sequencing by hybridisation
• CPC Class Codes: C12Q 2565/632 being a surface enhanced, e.g. resonance, Raman spectrometer

Abstract

Provided herein, is a nucleic acid sequencing method based on detection of Raman signatures of oligonucleotide probes. Raman signatures of individually captured nucleic acid probes, optionally labeled by a Raman label or a positively charged enhancer, are detected. The sequences of captured probes are used to identify the nucleotide sequences of captured probes and complementary target nucleic acids, which are then aligned and used to obtain nucleic acid sequence information. In another embodiment, a method is provided for determining a nucleotide occurrence at a target nucleotide position of a target nucleic acid, that utilizes binding of the target nucleic acid to a labeled oligonucleotide probe that binds to the target nucleic acid, wherein the labeled oligonucleotide probe includes a first label and a second label, the first label being capable of affecting an optical property of the second label.

Claims

1. A method for detecting a nucleic acid, comprising:

a) irradiating the nucleic acid with light, wherein the nucleic acid comprises a positively-charged enhancer; and

b) detecting a Raman signal generated by the irradiated nucleic acid.

2. The method of claim 1, wherein the positively charged enhancer is an amine group.

3. The method of claim 1, wherein the nucleic acid does not generate a detectable signal without the positively-charged enhancer.

4. The method of claim 1, wherein the nucleic acid consists of pyrimidine residues.